Received Jun 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
A female patient around 50 years old received Havrix on 2018 and did not complete the series.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 50-year-old female patient who received HAV (Havrix) for prophylaxis. Previously administered products included Havrix (received one dose in 2018). On an unknown date, the patient did not receive Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced incomplete course of vaccination (Verbatim: A female patient around 50 years old received Havrix on 2018 and did not complete the series.). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-JUN-2025 The reporter called to report that a patient around 50 years old who received a dose of Havrix on 2018 and had not completed the dosing schedule for Havrix. The reporter asked if she could get Twinrix. The reporter consented to follow up. Till the time of reporting, the patient did not receive the further dose of Havrix, which led to incomplete course of vaccination.